Building a Rationale for Evidence-Based Prolotherapy in an Orthopedic Medicine Practice: Part IV: Diagnosing Linked Prolotherapy Targets by Applying a Data-based Biotensegrity Model

Posted on Posted in Gary B. Clark, MD, MPA, Teaching Techniques, Volume 3 : Issue 3 : August 2011

By Gary B. Clark, MD, MPA Patients with sacral dysfunction routinely present sequentially-linked targets for Prolotherapy of varying severity from the plantar arch to the nuchal line. Part I of this series presented the logical development of Prolotherapy, highlighting Empirical, Deductive, Inductive, and Abductive analytical reasoning (IDEA).1 Part II discussed the application of the IDEA-based Scientific Method more »

Interview with Sherman O. Canapp Jr., DVM, MS, CCRT

Posted on Posted in Four-Legged Prolotherapy, Ross A. Hauser, MD, Sherman O. Canapp Jr., DVM, MS, CCRT, Volume 3 : Issue 3 : August 2011

By Ross A. Hauser, MD & Sherman O. Canapp Jr., DVM, MS, CCRT Dr. Canapp and assistant assessing a patient. Hauser: Dr. Canapp, as many of our readers know, another name for Prolotherapy is regenerative injection therapy. Could you tell us how you ended up getting interested in regenerative stem cell therapy? Canapp: I came across it in two different more »

Nutritional Support for Soft Tissue Healing

Posted on Posted in Margaret E. Taylor, MBBS, BSC, FACNEM, Volume 3 : Issue 3 : August 2011, Wonder Why?

By Margaret E. Taylor, MBBS, BSC, FACNEM ABSTRACT People who heal well obviously differ in some important way from those who we see with chronic non-healing lesions. The distinguishing feature is primarily the effectiveness of the healing cascade. Unless the factors contributing to this are considered, the outcome of Prolotherapy will also be affected. Research shows more »

Stem Cell Prolotherapy in Regenerative Medicine: Background, Theory and Protocols

Posted on Posted in Donna Alderman, DO, Gerald R. Harris, DO, Patrick C. Astourian, MS, PA-C, Robert W. Alexander, MD, DMD, FICS, Volume 3 : Issue 3 : August 2011, Wonder Why?

By Donna D. Alderman, DO, Robert W. Alexander, MD, DMD, FICS, Gerald R. Harris, DO, & Patrick C. Astourian, MS, PA-C ABSTRACT Prolotherapy is a proven technique for resolving musculoskeletal pain, but can have limitations if tissue damage is too severe. Platelet Rich Plasma (PRP) Prolotherapy offers a physiologic tool in some of those cases, but this too may more »

Autologous Fat Grafts as Mesenchymal Stromal Stem Cell Source for use in Prolotherapy: A Simple Technique to Acquire Lipoaspirants

Posted on Posted in Robert W. Alexander, MD, DMD, FICS, Volume 3 : Issue 3 : August 2011, Wonder Why?

ABSTRACT Objectives: Background for use of autologous adipose tissue as a source of adult progenitor (stem) cells for use in Prolotherapy. Present a means of lipoaspiration to harvest adipose-derived mesenchymal stromal cells (AD-MSC) and the stromal vascular fraction (SVF) for use in Prolotherapy and regenerative medical applications by non-plastic surgeons. Design: Explain the patented super luer-lok and more »

Prolotherapy and the Dilemma of Finding the Right Diagnosis

Posted on Posted in In the Spotlight, Jörn Funck, MD, Volume 3 : Issue 3 : August 2011

By Jörn Funck, MD If Prolotherapy is really as successful as always reported why is there only such a small group of experts existing all over the world? Dr. Hemwall, one of the pioneers of Prolotherapy once replied, “because it is too simple.” I agree with him on this point. Giving the precise injections is not more »

Stem Cell Prolotherapy is off to a Good Start

Posted on Posted in Great News Corner, Ross A. Hauser, MD, Volume 3 : Issue 3 : August 2011

By Ross A. Hauser, MD At the American Osteopathic Association of Prolotherapy Integrative Pain Management (AOAPIPM) meeting, April 7th-10th, in Naples, Florida, Donna Alderman, DO introduced the topic of Stem Cell Prolotherapy. The technique she utilizes was developed with the help of Robert W. Alexander, MD and involves the use of autologous adipose tissue as a source of more »